These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2677363)

  • 1. Terconazole. Pharmacology of a new antimycotic agent.
    Cauwenbergh G; Vanden Bossche H
    J Reprod Med; 1989 Aug; 34(8 Suppl):588-92. PubMed ID: 2677363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of 14 alpha-desmethyl sterol synthesis in Candida albicans by terconazole, a new triazole antimycotic.
    Isaacson DM; Tolman EL; Tobia AJ; Rosenthale ME; McGuire JL; Vanden Bossche H; Janssen PA
    J Antimicrob Chemother; 1988 Mar; 21(3):333-43. PubMed ID: 3129389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terconazole--a new antifungal agent for vulvovaginal candidiasis.
    Weisberg M
    Clin Ther; 1989; 11(5):659-68. PubMed ID: 2680088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticandidal activities of terconazole, a broad-spectrum antimycotic.
    Tolman EL; Isaacson DM; Rosenthale ME; McGuire JL; Van Cutsem J; Borgers M; Van den Bossche H
    Antimicrob Agents Chemother; 1986 Jun; 29(6):986-91. PubMed ID: 3729366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical basis for the activity and selectivity of oral antifungal drugs.
    Vanden Bossche H; Marichal P; Gorrens J; Coene MC
    Br J Clin Pract Suppl; 1990 Sep; 71():41-6. PubMed ID: 2091733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro activity of terconazole against yeasts: its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats.
    Van Cutsem J
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1200-6. PubMed ID: 1951575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terconazole cream for non-Candida albicans fungal vaginitis: results of a retrospective analysis.
    Sood G; Nyirjesy P; Weitz MV; Chatwani A
    Infect Dis Obstet Gynecol; 2000; 8(5-6):240-3. PubMed ID: 11220485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
    Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
    Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of clinical isolates of Candida spp. to terconazole and other azole antifungal agents.
    Pfaller MA; Gerarden T
    Diagn Microbiol Infect Dis; 1989; 12(6):467-71. PubMed ID: 2696620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of terconazole and clotrimazole vaginal tablets in the treatment of vulvovaginal candidosis.
    Kjaeldgaard A
    Pharmatherapeutica; 1986; 4(8):525-31. PubMed ID: 3520601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terconazole - a new broad-spectrum antifungal.
    Van Cutsem J; Van Gerven F; Zaman R; Janssen PA
    Chemotherapy; 1983; 29(5):322-31. PubMed ID: 6617296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of terconazole. United states experience.
    Thomason JL
    J Reprod Med; 1989 Aug; 34(8 Suppl):597-601. PubMed ID: 2677365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terconazole, a new triazole antifungal agent.
    Cartwrigth RY
    Gynakol Rundsch; 1985; 25 Suppl 1():6-11. PubMed ID: 4007624
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicans.
    Pfaller MA; Riley J; Koerner T
    Diagn Microbiol Infect Dis; 1990; 13(1):31-5. PubMed ID: 2184984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase (CYP51).
    Sun QY; Xu JM; Cao YB; Zhang WN; Wu QY; Zhang DZ; Zhang J; Zhao HQ; Jiang YY
    Eur J Med Chem; 2007 Sep; 42(9):1226-33. PubMed ID: 17335940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of action of anti-Candida drugs: focus on terconazole and other ergosterol biosynthesis inhibitors.
    Vanden Bossche H; Marichal P
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1193-9. PubMed ID: 1951574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of terconazole. European experience.
    Hirsch HA
    J Reprod Med; 1989 Aug; 34(8 Suppl):593-6. PubMed ID: 2677364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antifungal resistance in opportunistic pathogenic fungi (II). Imidazoles and triazoles].
    Martínez-Suárez JV; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):490-8. PubMed ID: 9011208
    [No Abstract]   [Full Text] [Related]  

  • 20. [Synthesis and antifungal activity of 1-(1,2,4-triazolyl-1H-1-yl)-2-(2,4-diflurophenyl)-3-(4-substituted benzyl-1-piperazinyl)-2-propanols].
    Sheng CQ; Zhang WN; Ji HT; Song YL; Yang S; Zhou YJ; Zhu J; Lü JG
    Yao Xue Xue Bao; 2003 Sep; 38(9):665-70. PubMed ID: 14730915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.